CCS
GNSS icon

Crosspoint Capital Strategies’s Genasys GNSS Stock Holding History

Crosspoint Capital Strategies’s Portfolio GNSS Stock Details GNSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-8,000
Closed -$22K – 392
2015
Q4 		$22K Buy
+8,000
New +$13.5K 0.01% 574

Other funds holding GNSS

AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $302M AUM 117.41% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SST
S Squared Technology New York $322M AUM 92.75% 1-Year Est. Return
FP
Foundry Partners Minneapolis, Minnesota $1.89B AUM 9.84% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return

Crosspoint Capital Strategies's GNSS Position: Q1 2016 in Review

Crosspoint Capital Strategies sold out of Genasys (GNSS) in Q1 2016, closing a stake of 8,000 shares — an estimated $22K sold.

Crosspoint Capital Strategies first reported a position in GNSS in Q4 2015 and held it in 1 quarter. The position peaked at $22K in Q4 2015. 36 funds tracked by Wall St. Rank hold GNSS as of Q1 2016.

  • Crosspoint Capital Strategies reported no remaining Genasys position as of Q1 2016 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 8,000 Genasys shares in Q1 2016, an estimated $22K.
  • Crosspoint Capital Strategies first reported a position in Genasys in Q4 2015 and held it in 1 quarter.
  • Crosspoint Capital Strategies's Genasys position peaked at $22K in Q4 2015.
  • 36 funds tracked by Wall St. Rank held Genasys as of Q1 2016.

Based on Crosspoint Capital Strategies's 13F filing for Q1 2016, filed 16 May 2016.